Email not displaying correctly? View it in your browser.

October 2016

Patient Care

Valve-in-valve therapy helps to extend the life of surgically placed bioprosthetic valves
Mayo's structural heart team provides comprehensive care to patients who have previously undergone surgery to replace the mitral or tricuspid valve with a tissue bioprosthesis. Existing dysfunctional bioprosthetic valves can be "replaced" with transcatheter valves.

Plasma ceramides test helps predict adverse cardiovascular events
A test for blood concentrations of plasma ceramides, a class of lipids linked to cardiovascular disease processes, is used with clinical evaluation and patient risk assessment to predict the risk of imminent adverse cardiovascular events in patients with coronary artery disease.

Early feasibility trials test experimental endovascular stents for complex aneurysms
New and individualized stent designs make it possible to treat aortic aneurysms with endovascular surgery, rather than conventional open surgery. Benefits include lower surgical mortality rates, less blood loss during the operation, less chance of complications and faster recovery.


PREVENT recommendations reduce patients' risk of pump thrombosis
The Prevention of HeartMate II Pump Thrombosis Through Clinical Management (PREVENT) trial evaluated the effect of treatment with a standardized management protocol on the incidence of pump thrombosis during the first three months after left ventricular assist device implant.

Genetic risk information for coronary heart disease leads to lower bad cholesterol
The Myocardial Infarction Genes (MI-GENES) Study also demonstrates the feasibility of placing genetic risk information into the electronic health record to empower patients and physicians to make decisions related to initiation of a statin medication.

Study explores antiplatelet medications based on genotype following coronary stent
The Tailored Antiplatelet Initiation to Lessen Outcomes Due to Decreased Clopidogrel Response After Percutaneous Coronary Intervention (TAILOR-PCI) study examines whether prescribing heart medication based on a patient's CYP2C19 genotype helps prevent cardiovascular death in patients after angioplasty.

See all Cardiac Surgery and Cardiovascular Diseases Clinical Trials at Mayo Clinic

Back to Top


Echocardiography in Pediatric and Adult Congenital Heart Disease Case Studies
Nov. 3-6, 2016, in Phoenix
Symposium highlights include anatomy and physiology of common congenital cardiac conditions and surgical and interventional procedures used to treat them, 2-D echo-Doppler hemodynamics in the setting of congenital heart disease, and limitations of echocardiography and other imaging techniques.

Coronary Artery Disease: Case-Based Learning
Nov. 18-20, 2016, in Las Vegas
This course addresses lifestyle interventions and primary preventive measures that improve cardiovascular prognosis, diagnostic and management strategies for patients with acute coronary syndromes and stable coronary artery disease, and imaging modalities for the detection and treatment of coronary artery disease.

The Heart Beat of Cardiology: Practical Application of Echocardiography
Dec. 8-10, 2016, in Chicago
Topics include interpretation of stress echocardiographic examinations, application of conventional and tissue Doppler techniques to diastolic function analysis, how to differentiate between athletic heart and hypertrophic cardiomyopathy, and practical knobology and image acquisition live scanning.

See all Cardiovascular Diseases Continuing Medical Education courses


Connect With Us

Twitter icon

Follow us on Twitter
Receive real-time news and thought-leading insights

Check us out on Medscape Cardiology
Mayo Clinic joins forces with Medscape Cardiology to bring you the latest perspective on clinical trials, patient care and news.

Consults & Referrals

Mayo Clinic
13400 E. Shea Blvd.
Scottsdale, AZ 85259

4500 San Pablo Road
Jacksonville, FL 32224

200 First St. SW
Rochester, MN 55905